The Limited Times

Now you can see non-English news...

Anthony Fauci on the Corona crisis: USA can do without AstraZeneca

2021-04-02T02:46:27.075Z


AstraZeneca's vaccine has not yet been approved for the US market. According to Anthony Fauci, virus expert and presidential advisor, that's not that bad.


Enlarge image

Anthony Fauci (in January)

Photo: JONATHAN ERNST / REUTERS

In contrast to numerous European countries, including Germany, the US has not yet approved AstraZeneca's corona vaccine.

This is cheaper and easier to store than other preparations - but there are always concerns about possible side effects.

Now the US epidemic expert Anthony Fauci has commented on the substance.

He believes the US won't need the AstraZeneca vaccine even if it were approved in the United States.

Fauci advises the White House on corona issues, among other things.

The head of the National Institute of Allergies and Infectious Diseases told Reuters, “My general feeling is that given the contractual relationships we have with a number of companies, we have enough vaccine to meet all of our needs without AstraZeneca in To claim. "

In Germany, the substance of the Swedish-British group is administered again after a forced break.

However, the federal government decided on Tuesday to inoculate the vaccine only on people over 60 years of age.

The background to this is thrombosis, particularly among younger women.

With 2.7 million AstraZeneca doses administered, 31 suspected cases of a so-called cerebral vein thrombosis were reported.

Younger people in vaccination groups one and two could "decide together with the vaccinating doctor at the doctor's discretion and with an individual risk analysis after careful explanation whether they want to be vaccinated with AstraZeneca," the decision said.

After the new age recommendation for the AstraZeneca corona vaccine came into force, the Standing Vaccination Commission recommended a different vaccine for a second vaccination to younger people who had been vaccinated.

Under 60-year-olds should be given a dose of the vaccine from Biontech / Pfizer or Moderna after twelve weeks instead of the second AstraZeneca vaccine dose, the panel announced on Thursday.

In SPIEGEL, the head of the Standing Vaccination Commission, Thomas Mertens, commented on the changing recommendations of his panel of experts regarding the AstraZeneca vaccine.

"The Paul Ehrlich Institute responsible for security monitoring in Germany had recognized a very clear signal that Stiko had to react to," said Mertens.

He does not see any damage to the image of the vaccination campaign.

"The current situation shows that the security system in Germany works".

It now depends on the redistribution in order not to endanger the vaccination rate.

»In Germany there are enough people over the age of 60 who want to be vaccinated against Covid-19 and have not yet been vaccinated.

You can get the vaccine from AstraZeneca.

So there are no vaccination doses to be dispensed with, ”says Mertens.

UK Authority: Benefits outweigh the vaccine

New figures are available from the UK on the risks of using the vaccine.

The local supervisory authorities reported a total of 30 cases that were affected by rare blood clots after the use of the AstraZeneca vaccine.

This is 25 cases more than previously reported.

The UK Medicines and Healthcare products Regulatory Agency says it has not received any such reports of blood clotting after using BioNTech and Pfizer vaccines.

The health authority said the benefits of the AstraZeneca vaccine they believed would outweigh the potential risk of blood clots.

jok / Reuters

Source: spiegel

All tech articles on 2021-04-02

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.